BeOne Medicines
ONC
#624
Rank
HK$304.17 B
Marketcap
HK$2,749
Share price
1.62%
Change (1 day)
58.36%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Market capitalization of BeOne Medicines (ONC)

Market cap: HK$304.17 Billion

As of February 2026 BeOne Medicines has a market cap of HK$304.17 Billion. This makes BeOne Medicines the world's 624th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BeOne Medicines from 2016 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$304.17 B13.09%
2025HK$268.96 B69.16%
2024HK$158.99 B3.27%
2023HK$153.96 B-22.52%
2022HK$198.71 B-8.3%
2021HK$216.70 B18.11%
2020HK$183.48 B130.58%
2019HK$79.57 B21.59%
2018HK$65.44 B88.22%
2017HK$34.77 B272.22%
2016HK$9.34 B

End of Day market cap according to different sources

On Feb 4th, 2026 the market cap of BeOne Medicines was reported to be:

HK$304.17 Billion
by Nasdaq info icon info icon
HK$304.17 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
OPKO Health
OPK
HK$7.74 B-97.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
HK$0.16 B-99.95%๐Ÿ‡บ๐Ÿ‡ธ USA